Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Bone Biologics Corporation has entered into a definitive agreement for a private placement offering of common stock and warrants expected to raise approximately $3 million initially, with potential total proceeds up to $9 million if all warrants are exercised. The funds will be used to support clinical trials, expand the patent portfolio, and for g…